ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
Health Care

Cutting-edge drugs must be affordable, Nobel laureate tells Davos

Stem cell researcher Yamanaka sees risk sharing as solution

Scientists build up stocks of stem cells at the Kyoto University institute headed by Nobel laureate Shinya Yamanaka. (Photo courtesy of the Center for iPS Cell Research and Application)

DAVOS, Switzerland -- A Japanese researcher who won the Nobel Prize for his work with stem cells said in a speech on Jan. 21 that developing advanced medical treatments needs to become faster and cheaper.

Shinya Yamanaka, director of the Center for iPS Cell Research and Application at Kyoto University, said the two major challenges facing regenerative medicine and new drug development are high costs and long development times

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more